Follow
Willem JG Melchers
Willem JG Melchers
Unknown affiliation
Verified email at radboudumc.nl
Title
Cited by
Cited by
Year
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism
E Snelders, HAL van der Lee, J Kuijpers, AJMM Rijs, J Varga, ...
PLoS medicine 5 (11), e219, 2008
8152008
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
PE Verweij, E Snelders, GHJ Kema, E Mellado, WJG Melchers
The Lancet infectious diseases 9 (12), 789-795, 2009
6762009
Genus-and species-specific identification of mycoplasmas by 16S rRNA amplification
FJ Van Kuppeveld, JT Van der Logt, AF Angulo, MJ Van Zoest, WG Quint, ...
Applied and environmental microbiology 58 (8), 2606-2615, 1992
6131992
Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
PE Verweij, A Chowdhary, WJG Melchers, JF Meis
Clinical Infectious Diseases 62 (3), 362-368, 2016
5712016
A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations
E Mellado, G Garcia-Effron, L Alcazar-Fuoli, WJG Melchers, PE Verweij, ...
Antimicrobial agents and chemotherapy 51 (6), 1897-1904, 2007
5252007
Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007–2009
JWM van der Linden, E Snelders, GA Kampinga, BJA Rijnders, ...
Emerging infectious diseases 17 (10), 1846, 2011
4912011
Multiple-triazole–resistant aspergillosis
PE Verweij, E Mellado, WJG Melchers
New England Journal of Medicine 356 (14), 1481-1483, 2007
4362007
Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
E Snelders, RAG Huis in't Veld, AJMM Rijs, GHJ Kema, WJG Melchers, ...
Applied and environmental microbiology 75 (12), 4053-4057, 2009
4262009
Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus
E Snelders, SMT Camps, A Karawajczyk, G Schaftenaar, GHJ Kema, ...
PloS one 7 (3), e31801, 2012
4172012
Whole-genome sequencing of bacterial pathogens: the future of nosocomial outbreak analysis
S Quainoo, JPM Coolen, SAFT van Hijum, MA Huynen, WJG Melchers, ...
Clinical microbiology reviews 30 (4), 1015-1063, 2017
4152017
Detection of high-grade prostate cancer using a urinary molecular biomarker–based risk score
L Van Neste, RJ Hendriks, S Dijkstra, G Trooskens, EB Cornel, ...
European urology 70 (5), 740-748, 2016
4122016
General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections
GJ Zoll, WJ Melchers, H Kopecka, G Jambroes, HJ Van der Poel, ...
Journal of clinical microbiology 30 (1), 160-165, 1992
4081992
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus
JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ...
Emerging infectious diseases 21 (6), 1041, 2015
3752015
Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles
JWM van der Linden, SMT Camps, GA Kampinga, JPA Arends, ...
Clinical infectious diseases 57 (4), 513-520, 2013
3732013
Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release
FJM van Kuppeveld, JGJ Hoenderop, RLL Smeets, PHGM Willems, ...
The EMBO journal, 1997
3541997
Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer
RLM Bekkers, LFAG Massuger, J Bulten, WJG Melchers
Reviews in medical virology 14 (2), 95-105, 2004
3262004
Aspergillus PCR: one step closer to standardization
PL White, S Bretagne, L Klingspor, WJG Melchers, E McCulloch, B Schulz, ...
Journal of clinical microbiology 48 (4), 1231-1240, 2010
3222010
Azole-resistance in Aspergillus: proposed nomenclature and breakpoints
PE Verweij, SJ Howard, WJG Melchers, DW Denning
Drug Resistance Updates 12 (6), 141-147, 2009
3042009
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2822005
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways
IAM van der Avoort, H Shirango, BM Hoevenaars, JMM Grefte, ...
International journal of gynecological pathology 25 (1), 22-29, 2006
2802006
The system can't perform the operation now. Try again later.
Articles 1–20